Daiichi Sankyo Terminates $650 Million Deal With This U.S. Pharma Post author:Sam Post published:August 30, 2017 Post category:BioPharma August 31, 2017By Alex Keown, BioSpace.com Breaking News Staff… Source: BioSpace You Might Also Like Massachusetts' Agenus Quietly Discloses Failure of Cancer Vaccine Trial February 21, 2017 <b>Gottlieb</b> Lays Out Plans to Attract and Preserve Top Talent at the FDA July 17, 2017 Kamada, Chiesi Farmaceutici Terminate Inhaled Alpha-1 Antitrypsin Therapy Deal November 19, 2017
